The University of Chicago Header Logo

Connection

Blase Polite to Carcinoma, Hepatocellular

Back to Details
This is a "connection" page, showing publications Blase Polite has written about Carcinoma, Hepatocellular.
Blase Polite
Connection Strength
0.068
Carcinoma, Hepatocellular
  1. Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma. Clin Cancer Res. 2012 Apr 01; 18(7):2090-8.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.